Blog

Insights from Guy Levy-Yurista, PhD – CEO of Synthace. About Guy: CEO of Synthace, a company that UKI2S has been supporting since investing at seed stage, now post series C having recently raised $35m Israeli-American with a Physics PhD and a Wharton MBA with 20 years of experience in both start-up and Fortune 500 environments […]

read more

 Figure Gilad Gershon, CEO of Tropic Biosciences The success of the UK in starting and growing biotech companies is well known, but for most people the sector is synonymous only with healthcare and new medicines. Beyond healthcare though, there are other important areas of our lives where biotechnology is making a difference. The agrifood industry […]

read more

SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology, is powering the synthetic biology industry, applying lab-based R&D excellence to fuel the development of tools, products, processes and services for high-value manufacturing industries. SynbiCITE’s four-day MBA course exemplifies this, helping develop the entrepreneurial and management skills in scientists required to run a biotechnology […]

read more

1 2 3 7